Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP286486.RAqe6MaJ5tNcmHFw61kpJMS1KklxJE0oEtr1NJmieP8jo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP286486.RAqe6MaJ5tNcmHFw61kpJMS1KklxJE0oEtr1NJmieP8jo130_assertion type Assertion NP286486.RAqe6MaJ5tNcmHFw61kpJMS1KklxJE0oEtr1NJmieP8jo130_head.
- NP286486.RAqe6MaJ5tNcmHFw61kpJMS1KklxJE0oEtr1NJmieP8jo130_assertion description "[In summary, HDMX exhibits bona fide oncogenic properties and offers a promising molecular target for GBM therapeutic intervention.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP286486.RAqe6MaJ5tNcmHFw61kpJMS1KklxJE0oEtr1NJmieP8jo130_provenance.
- NP286486.RAqe6MaJ5tNcmHFw61kpJMS1KklxJE0oEtr1NJmieP8jo130_assertion evidence source_evidence_literature NP286486.RAqe6MaJ5tNcmHFw61kpJMS1KklxJE0oEtr1NJmieP8jo130_provenance.
- NP286486.RAqe6MaJ5tNcmHFw61kpJMS1KklxJE0oEtr1NJmieP8jo130_assertion SIO_000772 20472715 NP286486.RAqe6MaJ5tNcmHFw61kpJMS1KklxJE0oEtr1NJmieP8jo130_provenance.
- NP286486.RAqe6MaJ5tNcmHFw61kpJMS1KklxJE0oEtr1NJmieP8jo130_assertion wasDerivedFrom befree-20140225 NP286486.RAqe6MaJ5tNcmHFw61kpJMS1KklxJE0oEtr1NJmieP8jo130_provenance.
- NP286486.RAqe6MaJ5tNcmHFw61kpJMS1KklxJE0oEtr1NJmieP8jo130_assertion wasGeneratedBy ECO_0000203 NP286486.RAqe6MaJ5tNcmHFw61kpJMS1KklxJE0oEtr1NJmieP8jo130_provenance.